Ligand validation:7UJV

OGA: N-OXALYLGLYCINE

OGA is a Ligand Of Interest in 7UJV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7UJV_OGA_B_501	96%	21%	0.072	0.983	1.69	1.62	2	2	0	0	100%	1
7Q5V_OGA_A_502	93%	11%	0.073	0.968	2.57	1.63	3	2	1	0	100%	1
5L9V_OGA_B_502	92%	13%	0.08	0.971	2.46	1.54	1	2	0	0	100%	1
6YW4_OGA_A_502	92%	9%	0.081	0.972	2.14	2.31	2	2	0	0	100%	1
5L9R_OGA_A_502	91%	16%	0.089	0.974	2.26	1.49	1	1	0	0	100%	1
5LAS_OGA_B_502	79%	14%	0.119	0.964	2.37	1.48	1	2	0	0	100%	1
4GJY_OGA_A_502	100%	25%	0.024	0.993	2.38	0.72	2	-	0	0	100%	1
3MS5_OGA_A_390	99%	26%	0.048	0.984	1.22	1.76	1	3	0	0	100%	1
5A1F_OGA_A_1756	99%	17%	0.054	0.985	2.18	1.44	2	2	0	0	100%	1
6F4T_OGA_A_502	98%	14%	0.053	0.979	2.26	1.62	4	2	0	0	100%	1
6F4R_OGA_A_502	98%	20%	0.062	0.984	1.98	1.4	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.